Galvecta plus (vildagliptin + metformin HCL) tablets are manufactured by NovaMed Pharmaceuticals Pvt. Ltd and marketed by Pharmevo. Biz.
This medicine is used in the treatment of patients with diabetes mellitus type 2.
Each pack contains:
Each 50/850mg pack of Galvecta contains 14 tablets.
Each film coated tablet contains:
This medicine is indicated for the treatment of diabetes mellitus type 2. It is indicated as an add-on to insulin as an adjunct to diet and exercise to improve glycemic control in patients.
This medicine is recommended by doctors when a stable dose of insulin and metformin do not provide adequate glycemic control. However, treatment should not be initiated with this fixed-dose combination.
Caution and side effects:
This medicine is not a substitute to insulin and should not be prescribed to pregnant women as it is reported to affect fetal growth. This medicine should not be used to treat diabetes type 1 patients. Joint pain, severe or persist is reported on the usage of this medicine.
Dosage and instructions:
As advised by the physician. The recommended daily dose of this medicine is 100mg vildagliptin plus 2000mg metformin hydrochloride.
Keep all medicines out of reach of children. To be sold on the prescription of registered medical practitioners only.
Protect from light, heat, and moisture. Store below 30 degrees Celsius. For details, please see the enclosed leaflet insert.
You can contact the manufacture at: https://www.novamedpharma.com
Galvecta plus is marketed by: https://pharmevo.biz
You can buy this medicine online at https://www.emeds.pk
By: javairia Israr